CHANGSHA, Dec. 11 (Xinhua) -- Chinese researchers have successfully extracted high-purity lead-212 and bismuth-212 nuclides from rare earth minerals, the press center of the University of South China said Wednesday.

This breakthrough holds significant importance for achieving self-sufficiency in the production of critical medical nuclides in China, according to the research team.

These nuclides are known for their potential in targeted alpha-nuclide therapy (TAT), a promising treatment for various cancers, including breast, pancreatic and prostate cancer, according to the press center.

However, their supply remains severely limited. The extraction of lead-212 and bismuth-212 nuclides from natural thorium is expected to fundamentally address this issue.

The team of researchers established and verified a new, efficient and low-cost method for separating lead-212 and bismuth-212 nuclides in halide medium from natural thorium-232 decay-chain through a new adsorbent material -- a silica-supported anion exchange resin (SiPyR-N4). The adsorption speed was over six times faster than that of traditional resins, offering significant advantages in separating short-lived nuclides.

In addition to lead-212 and bismuth-212, the team is also working on extracting radium-228, thorium-228 and radium-224 nuclides, according to Wei Yuezhou, a professor leading the research team.

The team has applied for the national invention patent for these research findings, which have already been published in several major international journals. Enditem

Related

Go to Forum >>0 Comment(s)